Subscribe To
Sale rumors of novartis' sandoz unit are heating up
How to spend $45 billion is a nice problem to have. That's the sum Swiss pharmaceutical giant Novartis ...
February 1, 2022, 5:02 pm
Sale rumors of novartis' sandoz unit are heating up
How to spend $45 billion is a nice problem to have. That's the sum Swiss pharmaceutical giant Novartis ...
February 1, 2022, 5:02 pm
Analysts estimate deciphera pharmaceuticals, inc. (dcph) to report a decline in earnings: what to look out for
Deciphera pharmaceuticals, Inc. (DCPH) doesn't possess the right combination of the two key ingredients...
February 1, 2022, 4:09 pm
Analysts estimate deciphera pharmaceuticals, inc. (dcph) to report a decline in earnings: what to look out for
Deciphera pharmaceuticals, Inc. (DCPH) doesn't possess the right combination of the two key ingredients...
February 1, 2022, 4:09 pm
Analysts estimate deciphera pharmaceuticals, inc. (dcph) to report a decline in earnings: what to look out for
Deciphera pharmaceuticals, Inc. (DCPH) doesn't possess the right combination of the two key ingredients...
February 1, 2022, 4:09 pm
Here's why you should retain west pharmaceutical (wst) now
West pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Product...
February 1, 2022, 1:04 pm
Here's why you should retain west pharmaceutical (wst) now
West pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Product...
February 1, 2022, 1:04 pm
Here's why you should retain west pharmaceutical (wst) now
West pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Product...
February 1, 2022, 1:04 pm
Bofa downgrades ionis after vupanorsen setback: are there upcoming catalysts that can help the stock?
Ionis pharmaceuticals Inc IONS announced on Monday the discontinuation of the Vupanorsen clinical deve...
February 1, 2022, 12:21 pm
Bofa downgrades ionis after vupanorsen setback: are there upcoming catalysts that can help the stock?
Ionis pharmaceuticals Inc IONS announced on Monday the discontinuation of the Vupanorsen clinical deve...
February 1, 2022, 12:21 pm
Bofa downgrades ionis after vupanorsen setback: are there upcoming catalysts that can help the stock?
Ionis pharmaceuticals Inc IONS announced on Monday the discontinuation of the Vupanorsen clinical deve...
February 1, 2022, 12:21 pm
Rigel pharmaceuticalsa biopharma with a free shot on goal in covid-19, with a pipeline as a safety net
Rigel pharmaceuticalsA Biopharma With A Free Shot On Goal In COVID-19, With A Pipeline As A Safety Net...
February 1, 2022, 11:48 am
Rigel pharmaceuticalsa biopharma with a free shot on goal in covid-19, with a pipeline as a safety net
Rigel pharmaceuticalsA Biopharma With A Free Shot On Goal In COVID-19, With A Pipeline As A Safety Net...
February 1, 2022, 11:48 am
Rigel pharmaceuticalsa biopharma with a free shot on goal in covid-19, with a pipeline as a safety net
Rigel pharmaceuticalsA Biopharma With A Free Shot On Goal In COVID-19, With A Pipeline As A Safety Net...
February 1, 2022, 11:48 am
Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst pharmaceuticals, Inc. (Nasdaq:...
February 1, 2022, 9:25 am
Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst pharmaceuticals, Inc. (Nasdaq:...
February 1, 2022, 9:25 am
Biocryst to present new orladeyo® (berotralstat) data at 2022 american academy of allergy, asthma & immunology annual meeting
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- BioCryst pharmaceuticals, Inc. (Nasdaq:...
February 1, 2022, 9:25 am
Here's what to know about vertex pharmaceuticals' earnings report
Its plan to diversify into new therapy areas is continuing to take shape....
February 1, 2022, 8:55 am
Here's what to know about vertex pharmaceuticals' earnings report
Its plan to diversify into new therapy areas is continuing to take shape....
February 1, 2022, 8:55 am
Here's what to know about vertex pharmaceuticals' earnings report
Its plan to diversify into new therapy areas is continuing to take shape....
February 1, 2022, 8:55 am